Cellipont Bioservices
PrivateLast Round
Growth Equity
Oct 7, 2024
Company Overview
Cellipont Bioservices operates in Healthcare & Life Sciences and is based in The Woodlands, Texas. Its latest recorded funding round was a Growth Equity round in October 2024.
Cellipont Bioservices is a biotechnology company that provides contract development and manufacturing organization (CDMO) services for cell and gene therapy products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Pharma Supply Chain, Compliance
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellipont Bioservices Comparables
Compare Cellipont Bioservices with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kincell Bio | 93% | |
| Theragent | 89% | |
| Andelyn Biosciences | 88% |
For institutional investors. Book with your work email.
Cellipont Bioservices Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Oct 7, 2024 | ||||
| Debt | Mar 21, 2023 | ||||
| Buyout/LBO | Jan 11, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cellipont Bioservices Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OrbiMed | Debt |
| Great Point Partners | Growth Equity, Buyout/LBO |
| HealthQuest Capital | Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 7, 2024
Led by HealthQuest Capital and Great Point Partners.
- Mar 21, 2023
Debt round led by OrbiMed
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- merges_withSep 17, 2026
Cellipont Bioservices and Kincell Bio, LLC complete their combination in the United States to form Kincellis Advanced Therapies, a CDMO focused on cell therapies and other advanced modalities, on Sep 17th '26.
- attends_eventSep 9, 2026
Cellipont Bioservices plans to attend the 11th CAR-TCR Summit in Massachusetts from Sep 15th–17th '26, where automated manufacturing and the scalability of next-generation cell therapies are key discussion topics.
For institutional investors. Book with your work email.
Cellipont Bioservices Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cellipont Bioservices's valuation, stock price, and market status.
Is Cellipont Bioservices a public or private company?
Cellipont Bioservices is a private company.
What is the current stock price of Cellipont Bioservices?
Cellipont Bioservices is a private company, so its shares have no public market price. Caplight tracks Cellipont Bioservices's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cellipont Bioservices worth (valuation)?
Valuation information for Cellipont Bioservices is not publicly available.
Can I buy Cellipont Bioservices stock?
Cellipont Bioservices shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cellipont Bioservices's last funding round?
Cellipont Bioservices's most recent funding round was Growth Equity on October 7, 2024.
Who are the main investors in Cellipont Bioservices?
Key investors in Cellipont Bioservices include OrbiMed, Great Point Partners, HealthQuest Capital.
Will Cellipont Bioservices IPO soon?
No public IPO plans have been announced for Cellipont Bioservices.
How can I track Cellipont Bioservices secondary market activity?
Caplight tracks bids, offers, and trades in Cellipont Bioservices's shares on secondary markets.